Quintiles and IMS Health Announce Global Collaboration to Advance the Use of Next-Generation Real-World Evidence in Late-Stage Clinical Research

RESEARCH TRIANGLE PARK, N.C. & DANBURY, Conn.--(BUSINESS WIRE)--Quintiles and IMS Health today announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. With complementary strengths in real-world data management, operational delivery, advanced analytics, and scientific and therapeutic expertise, the collaboration will accelerate assessments of treatment impact and help improve patient outcomes.